The urgent need for digital transformation in plasma-derived therapies is driven by the reliance on plasma donations, requiring hundreds to thousands for a single patient’s annual treatment.
To ensure patient needs are met, we must optimize our plasma collection process and innovate to expand our donor community through education and advocacy.
Takeda's BioLife organization operates over 260 global plasma donation centers, tackling challenges akin to retail businesses while focusing on retaining donors who can save lives.
Through innovative technologies like machine learning and AI, we aim to personalize plasma donation, streamline the manufacturing process, and enhance the overall treatment experience for patients.
Collection
[
|
...
]